Leishmania donovani: Immunization against Infection as a Function of Parasite Growth Phase

J. C. Jarecki-Black Departments of Laboratory Medicine and Ophthalmology, Medical University of South Carolina, Charleston, South Carolina 29425

Search for other papers by J. C. Jarecki-Black in
Current site
Google Scholar
PubMed
Close
,
E. R. James Departments of Laboratory Medicine and Ophthalmology, Medical University of South Carolina, Charleston, South Carolina 29425

Search for other papers by E. R. James in
Current site
Google Scholar
PubMed
Close
,
J. W. Kirshtein Departments of Laboratory Medicine and Ophthalmology, Medical University of South Carolina, Charleston, South Carolina 29425

Search for other papers by J. W. Kirshtein in
Current site
Google Scholar
PubMed
Close
,
J. D. Kirshtein Departments of Laboratory Medicine and Ophthalmology, Medical University of South Carolina, Charleston, South Carolina 29425

Search for other papers by J. D. Kirshtein in
Current site
Google Scholar
PubMed
Close
, and
A. B. Glassman Departments of Laboratory Medicine and Ophthalmology, Medical University of South Carolina, Charleston, South Carolina 29425

Search for other papers by A. B. Glassman in
Current site
Google Scholar
PubMed
Close
Restricted access

C57BL/6 mice were immunized against Leishmania donovani infection with a subcutaneous vaccination protocol. Groups received 3 injections at 4-day intervals combining glucan and killed promastigotes harvested from either logarithmic or stationary phase cultures. Controls were immunized with glucan alone, stationary or log phase promastigotes alone, or were untreated. All groups were challenged intravenously with stationary phase promastigotes at day 45 post-immunization. Results revealed that animals immunized with the glucan-killed parasite vaccine, utilizing promastigotes derived from either log (GPL) or stationary phase cultures (GPs), demonstrated significant resistance against infection as compared to controls or untreated mice. Additionally, the reduction in hepatic amastigote proliferation in mice immunized with GPs was significantly greater than in mice immunized with GPL.

Author Notes

Save